I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Wet AMD and Sudden Vision Loss
Understanding Wet AMD
To understand wet AMD, it helps to start with the part of the eye it affects and why that part matters so much to your daily vision.
The macula is the small central area of the retina, roughly the size of a pencil eraser, that processes the sharp detail you rely on for reading, driving, and recognizing faces. When the macula is damaged, central vision becomes blurry, distorted, or dark. Side vision, also called peripheral vision, is generally preserved, but the loss of central vision affects most everyday tasks.
Wet AMD occurs when abnormal blood vessels begin to grow beneath the retina in a process called choroidal neovascularization. These vessels are fragile and prone to leaking blood and fluid into the layers of the macula. A protein called vascular endothelial growth factor, or VEGF, drives this abnormal growth. The leaking fluid damages delicate retinal tissue and can cause vision to change rapidly. Without treatment, the leaking vessels may form a scar called a disciform scar, which replaces healthy retinal tissue with fibrous material and leads to permanent central vision loss.
AMD has two forms. Dry AMD is the more common form and tends to progress slowly over many years. Wet AMD is less common but far more serious, capable of causing dramatic vision changes within days to weeks. Although wet AMD accounts for a smaller portion of all AMD cases, it is responsible for the large majority of AMD-related severe vision loss.
It is also important to know that dry AMD can convert to wet AMD at any time, even when vision feels stable. This is why anyone diagnosed with any form of AMD needs regular monitoring by a retina specialist.
Who Is at Risk for Wet AMD
AMD affects millions of adults, and certain factors make some people more likely to develop the wet form of the disease. Understanding your personal risk helps guide how often you should be evaluated.
The single greatest risk factor for AMD is age. Risk increases significantly after 50 and rises with each passing decade. A family history of AMD also matters. If a parent or sibling has been diagnosed, your own risk is higher. Genetic factors can influence both whether you develop AMD and how quickly it may progress.
AMD is diagnosed more often in people of European or Caucasian descent, and women are affected at higher rates than men. These patterns do not mean AMD cannot develop in other groups, but they reflect differences in baseline risk across populations.
Several lifestyle and medical conditions can increase the likelihood of developing AMD or accelerate its course. Many of these factors can be modified, meaning that changes you make today may reduce your risk going forward.
- Smoking significantly raises the risk of AMD and is one of the most controllable risk factors
- A diet low in antioxidants, leafy green vegetables, and omega-3 fatty acids may contribute to higher risk
- High blood pressure and cardiovascular disease are associated with greater AMD susceptibility
- Being overweight, particularly with excess abdominal weight, is linked to elevated risk
- Long-term exposure to ultraviolet light without protective eyewear may contribute to retinal damage over time
Recognizing the Warning Signs
Wet AMD often announces itself quickly. Knowing what to look for can help you seek care before lasting damage occurs.
Unlike dry AMD, which develops gradually, wet AMD can produce noticeable changes in central vision over hours or days. Common symptoms include:
- A sudden blurring or darkening of central vision in one eye
- Straight lines, such as door frames or printed text, appearing wavy or bent
- A dark or blank spot appearing in the center of your visual field
- Colors that seem less vivid or appear washed out
- Difficulty reading fine print, recognizing faces, or seeing fine detail clearly
An Amsler grid is a simple paper tool that resembles graph paper with a dot at its center. It is designed to help you detect early changes in your central vision between scheduled appointments. Testing takes less than a minute per day and is one of the most useful habits for anyone with AMD or at high risk for it.
To use it, cover one eye and stare at the central dot in good lighting. Note whether any lines look wavy, broken, or missing, or whether any area of the grid appears dark or absent. If you notice a new change that was not there the day before, contact a retina specialist promptly. Even subtle findings are worth reporting right away.
Sudden changes in central vision should be treated with the same urgency as a stroke or heart attack. If you notice a sudden loss of central vision, new distortion, or a dark spot appearing quickly, contact a retina specialist or go to the emergency room immediately. Evidence supports the idea that beginning treatment within the first 48 hours of symptom onset is associated with better visual outcomes. Do not wait to see if the symptoms resolve on their own.
How We Diagnose Wet AMD
Diagnosing wet AMD requires a comprehensive eye examination along with specialized imaging that allows our physicians to examine the layers of the retina in precise detail. Each test provides a different and valuable view of what is happening beneath the surface of your eye.
The first step in evaluating the retina is a dilated eye exam. We use drops to widen the pupil so we can examine the retina and macula directly. During this exam, we look for signs of abnormal blood vessel growth, fluid accumulation, or bleeding beneath the retina. This examination is the foundation of any complete retinal evaluation.
Optical coherence tomography, or OCT, is a noninvasive imaging test that creates detailed cross-sectional pictures of the retina. It can reveal fluid within or beneath the retinal layers, swelling, and subtle structural changes that are not visible during a standard exam. OCT is one of the most essential tools we use to diagnose wet AMD and to monitor how the retina responds to treatment over time.
In fluorescein angiography, a special dye is injected into a vein in the arm. As the dye travels through the retinal blood vessels, a camera captures a rapid sequence of photographs that reveal exactly where abnormal vessels are located and where fluid is leaking. This test helps us understand the extent and pattern of disease activity, which guides treatment planning.
OCT angiography, or OCTA, is a newer imaging technique that maps blood flow through the retina without requiring an injected dye. It produces detailed images of both normal and abnormal blood vessels and gives us additional information about the activity and structure of the disease. We may use OCTA alongside other imaging tests to form a complete picture of your condition and monitor changes across visits.
Treatment for Wet AMD
The primary treatment for wet AMD is anti-VEGF therapy, a class of medication delivered by injection directly into the eye. These treatments have transformed outcomes for wet AMD and allow many patients to maintain or improve their vision over the long term.
Anti-VEGF medications work by blocking vascular endothelial growth factor, the protein that triggers abnormal blood vessel growth and leaking beneath the retina. By targeting VEGF, these drugs reduce fluid in the macula and help stabilize the retina. The injection is called an intravitreal injection, meaning it is delivered into the vitreous, the gel-filled interior of the eye.
Before each injection, numbing drops are applied to make the procedure as comfortable as possible. Most patients report only mild pressure or very brief discomfort. The injection itself takes only a few seconds, and the entire appointment is typically brief.
Several anti-VEGF medications are currently approved and in use for wet AMD. Your physician will recommend the most appropriate option based on your individual circumstances and how your eye responds over time.
- Aflibercept (Eylea) is typically given every four to eight weeks after an initial loading phase
- Ranibizumab (Lucentis) is typically given every four weeks
- Faricimab (Vabysmo) is a bispecific antibody that targets two disease pathways and may allow dosing every four to sixteen weeks in some patients
- Bevacizumab (Avastin) is widely used for wet AMD and is typically given every four to six weeks
Newer medications and formulations may allow some patients to receive fewer injections per year without sacrificing treatment benefit. High-dose aflibercept (Eylea HD) and faricimab (Vabysmo) have demonstrated the ability to maintain treatment effects with longer intervals between doses for certain patients. Some individuals may be able to extend time between visits to every three to four months. Your physician will determine the appropriate schedule based on how your retina responds and what imaging shows.
The timing of treatment is one of the most important factors in preserving vision after wet AMD develops. Evidence supports the idea that beginning anti-VEGF therapy as soon as possible after symptoms begin leads to better visual outcomes. Once a disciform scar has formed in the macula, the vision loss it causes is very difficult to reverse. This is why any sudden change in central vision should lead to an immediate call to our office or a visit to the nearest emergency room. Time matters.
What to Expect During Treatment
Starting treatment for wet AMD involves a structured process that evolves over time based on how your eye responds. Understanding what lies ahead can reduce uncertainty and help set realistic expectations from the beginning.
Treatment typically begins with a series of monthly injections called a loading phase. This usually involves three injections given approximately four weeks apart. The loading phase delivers consistent medication to the eye to bring active disease under control as efficiently as possible.
After the loading phase, we use OCT imaging and clinical evaluation to assess how your eye is responding. Based on those findings, we create an ongoing treatment plan that may involve monthly, every-other-month, or longer-interval injections, depending on individual response. Some patients require ongoing treatment to keep the disease stable. Regular monitoring visits remain essential even during stable periods, because wet AMD can reactivate without obvious early symptoms.
Anti-VEGF therapy can stabilize wet AMD and, in many cases, lead to meaningful improvement in visual sharpness. However, no current treatment eliminates AMD or offers a permanent cure. The goal is to control the disease, reduce fluid and bleeding, and protect as much vision as possible over time. Patients who begin treatment before significant scarring has occurred tend to have the best outcomes. Some experience notable visual improvement, while others maintain their current level of vision without further decline. Both are meaningful results.
Living Well With Wet AMD
Managing wet AMD is an ongoing process that extends well beyond your visits to our office. There are real and practical steps you can take every day to protect your vision and quality of life.
Certain lifestyle changes may help protect your remaining vision and support retinal health over time. Quitting smoking is one of the most impactful steps anyone with AMD can take. Eating a diet rich in leafy green vegetables, colorful fruits, fish, and foods high in antioxidants and omega-3 fatty acids may also be beneficial. Maintaining a healthy weight, managing blood pressure, controlling cardiovascular risk factors, and wearing sunglasses that block ultraviolet light are all steps worth building into your routine.
Checking your central vision with an Amsler grid every day is a simple habit that can have real consequences for your outcomes. Test one eye at a time in good lighting, and compare what you see to your previous observations. If you notice any new distortion, waviness, or dark spots, contact us before your next scheduled appointment. Catching a recurrence of fluid or new disease activity early gives us the best opportunity to re-treat before further damage accumulates.
For patients who have already experienced significant central vision loss, low vision rehabilitation can help maximize what remains. Low vision specialists can recommend magnifying devices, specialized lighting systems, electronic reading tools, and other adaptive strategies. These resources help people continue reading, cooking, navigating their homes, and remaining active in daily life with greater independence.
A diagnosis of wet AMD, especially when vision changes happen suddenly, can be emotionally difficult. Feelings of fear, frustration, and grief are common and completely understandable. Connecting with others who are navigating similar experiences through a support group can provide both practical insight and emotional encouragement. Organizations such as the American Macular Degeneration Foundation and the BrightFocus Foundation offer free resources, helplines, and community connections for patients and their caregivers.
When to Contact a Retina Specialist
Knowing when to seek urgent care versus scheduling a routine visit can protect your vision. Some situations require immediate attention, while others call for consistent, ongoing follow-up.
If you experience any of the following, do not wait for your next scheduled appointment. Seek care from a retina specialist or go to the emergency room right away.
- Sudden loss of central vision in one or both eyes
- A new dark or blank area appearing in the center of your visual field
- Straight lines that suddenly look wavy or distorted
- Rapidly worsening visual distortion developing over hours or days
If you have been diagnosed with dry AMD, regular monitoring visits are essential even when your vision feels unchanged. Dry AMD can convert to wet AMD without warning, and that transition may not cause immediate symptoms. Adults over 50 with a family history of AMD, retinal deposits called drusen, or other risk factors should have a comprehensive dilated exam at least once a year, and more frequently if recommended by your specialist. Your monitoring schedule will be tailored to your individual level of risk.
Frequently Asked Questions
Below are answers to questions patients commonly raise once they learn more about wet AMD, its treatment, and what to expect going forward.
The answer depends largely on how soon treatment begins and whether a scar has already formed in the macula. Anti-VEGF therapy can improve vision in patients who receive care before significant scarring occurs. Once a disciform scar has developed, the damage within that area is generally permanent and cannot be reversed by current treatments. However, treatment can still protect the surrounding retina and prevent further progression, which remains an important and meaningful goal even when some loss has already occurred.
During stable periods, wet AMD can quietly reactivate before producing obvious symptoms. This is one of the most important reasons why regular OCT scans continue even when you feel your vision is fine. At home, daily Amsler grid testing is your early detection system between appointments. If you notice any new waviness, darkening, or distortion that was not present the day before, contact us right away rather than waiting for your next scheduled visit. Catching reactivation early typically allows us to restore stability with less impact on vision.
Delaying or skipping injections without direction from your physician can allow the disease to become active again, often without early visible warning. OCT imaging frequently shows fluid returning before any symptoms are noticeable to the patient. Your specialist tracks your treatment interval carefully and bases decisions on imaging findings, not symptoms alone. If you have concerns about the frequency of injections or how they affect your daily life, bring those concerns to your physician so that any adjustments can be made safely and with full awareness of the risks.
Yes, this is entirely possible. Different forms of AMD can exist in each eye independently, or both forms can be present within the same eye. Many patients with active wet AMD also have areas of dry AMD alongside it. Your physician evaluates each eye separately at every visit, and your treatment plan reflects the needs of each eye individually. This is also why daily Amsler grid testing should be done one eye at a time, covering the other eye completely while you test.
Geographic atrophy is a form of advanced dry AMD in which patches of retinal cells in the macula are permanently lost over time. It does not typically cause the sudden vision changes associated with wet AMD, but it can lead to meaningful visual decline. Two intravitreal treatments have been approved specifically to help slow the progression of geographic atrophy, and these are distinct from the anti-VEGF medications used for wet AMD. If you have been diagnosed with geographic atrophy or are concerned about advanced dry AMD, your retina physician can evaluate whether these options are appropriate for your specific situation.
Without treatment, the abnormal blood vessels in wet AMD continue to leak fluid and blood beneath the retina. Over time, this leads to scarring of the macula and severe, lasting central vision loss. Peripheral vision is generally preserved, but the loss of central vision makes reading, driving, recognizing faces, and most everyday tasks extremely difficult. The damage caused by scarring cannot currently be reversed, which is why prompt evaluation and treatment from the very first symptom are so critical to long-term outcomes.
See Our Retina Specialists
New England Retina Associates is a retina-only practice with fellowship-trained vitreoretinal specialists who are experienced across the full range of retinal diseases, including all forms of AMD. We welcome patients from across Connecticut who are experiencing sudden vision changes, managing an existing diagnosis, or seeking a second opinion. Early evaluation is the single most important step you can take to protect your vision, and our team is here to guide you through every stage of care with expertise and compassion.
30 Years of Care & Commitment
